Company Name Aquinnah Pharmaceuticals
Mailing Address 700 Main Street North Cambridge, MA 02139 USA
Company Description Aquinnah Pharmaceutical’s approach is unique by integrating human genetic, human pathology and cellular biology R&D expertise, towards the development of a new therapeutic approach. Our approach has the potential to treat the majority of patients with ALS (Amyotrophic Lateral Sclerosis), also known as Lou Gehrig’s disease.
Proceeds Purposes This funding adds further momentum to the numerous peer reviewed grants that we have received and will accelerate our program toward clinical development of new drugs for ALS and other neurodegenerative diseases.